Clinical Trial

Use of a New Diagnostic Tool in the Detection and Characterization of Endometriosis Lesions

Study acronym: ENDO-TEP

Recruiting

Summary

Diagnostic wandering is one of the characteristics of endometriosis due to great anatomical and clinical variability but also due to poorly relevant diagnostic examinations. \[18F\]-FES PET/CT could on the one hand improve diagnosis by showing greater sensitivity than MRI and on the other hand make it possible to quantify and characterize the expression of ER from diagnosis and thus helping to guide therapeutic care. We will thus attempt to correlate the intensity of \[18F\]-FES PET/CT with the expression of estrogen receptors and the intensity of pain.

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2025-06-26.

Status change: Not Yet Recruiting → Recruiting 2026-03-24

Trial Details

NCT Number	NCT07053982
Lead Sponsor	University Hospital, Toulouse
Conditions	Endometriosis
Enrollment	20 participants
Start Date	2026-03-23
Primary Completion	2028-03 (estimated)
Study Completion	2028-03 (estimated)
Updated on ClinicalTrials.gov	2026-03-25